News
Clinical Trials Arena on MSN22h
Enrolment concludes in Phase III trial of Dizal’s sunvozertinib for NSCLCThe trial is being carried out in 16 nations and regions, including Asia, North America, Europe, and South America.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback